Last reviewed · How we verify
NCT05803330
Study of Alpha-blockers Alone During Preoperative Preparation in Patients With Pheochromocytoma
NA trial testing Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma in Adrenal Pheochromocytoma in 95 participants. Completed in 20 October 2022.
20 October 2022
Quick facts
| Lead sponsor | Kunwu Yan,MM |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 95 |
| Start date | 20 February 2014 |
| Primary completion | 20 October 2022 |
| Estimated completion | 20 October 2022 |
Drugs / interventions tested
- Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma
Conditions studied
- Adrenal Pheochromocytoma — all drugs for Adrenal Pheochromocytoma →
- Hemodynamic — all drugs for Hemodynamic →
Sponsor
Kunwu Yan,MM
Who can join
Adults 18 to 85, any sex, with Adrenal Pheochromocytoma or Hemodynamic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study of the relationship between hemodynamic stability and preoperative intravenous rehydration in patients with pheochromocytoma
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05803330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05803330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kunwu Yan,MM
- Last refreshed: 7 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05803330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing